DH
$207.66
-3.37
(-1.60%)
As of Sep 5, 2026, 9:14 AM EDT · cached
Price history
Danaher Corporation (DHR) is trading down at $207.66 (-1.60%) on NYSE/NASDAQ, as of the latest quote. It is a S&P 500 constituent in the Health Care sector.
Recent News (20)
-
WHO Grants Emergency Use Listing for Cepheid's Xpert® Hemorrhagic Fever Panel Test to Support Ebola Outbreak Response in the DRC Extensive GeneXpert® Dx system footprint across Africa enables rapid deployment of decentralized molecular testing where it is needed most SUNNYVALE, Calif., Sept. 3, 2026 /PRNewswire/ -- Cepheid, a D…
-
Danaher (DHR) Seen Deftly Navigating AI Integration
Danaher (DHR) Seen Deftly Navigating AI Integration
-
Mammotome Accelerates Production as Public Health Response to Nationwide Breast Biopsy Needle Shortage Cincinnati-based breast care company expands capacity and provider support to help minimize diagnostic delays and restore patient access to critical procedures CINCINNATI, Sept. 3, 2026 /PRNewswire/ -…
-
Is Danaher Stock Underperforming the Nasdaq?
Is Danaher Stock Underperforming the Nasdaq?
-
Why Danaher (DHR) Remains a Healthcare Compounder to Watch
Why Danaher (DHR) Remains a Healthcare Compounder to Watch
-
Danaher president & CEO Rainer Blair sells $12.7 million in company stock
Danaher president & CEO Rainer Blair sells $12.7 million in company stock
-
BRC Therapeutics Appoints Biopharma Veteran Chandra Ramanathan as Executive Vice President of Commercialization and Strategy Seasoned Executive Brings Track Record of Drug Launches, External Innovation, and Portfolio Growth at Bristol Myers Squibb, Wyeth, Bayer, and Danaher to BRC's Next Phase of Growth MONTEREY, Calif., Au…
-
Danaher vs. Intuitive Surgical: Is Recovery or Innovation the Better Long-Term Bet?
Danaher vs. Intuitive Surgical: Is Recovery or Innovation the Better Long-Term Bet?
-
Danaher vs. Medtronic: Which Healthcare Recovery Story Has More Upside?
Danaher vs. Medtronic: Which Healthcare Recovery Story Has More Upside?
-
-
-
Leica Biosystems Enables Faster Cancer Diagnoses Through Multiple Digital Pathology FDA Clearances, Including Industry-First AI-Assisted Quality Control Software Portfolio expansion marks new era for diagnosis delivery, translating digital pathology innovation to clinical impact by accelerating workflows and patient care VISTA, Calif., Aug. 11, 2026 /PRNewswir…
-
Thermo Fisher (TMO) vs Danaher (DHR): Which Life Sciences Stock Looks Better Positioned? Thermo Fisher (TMO) vs Danaher (DHR): Which Life Sciences Stock Looks Better Positioned?
-
Thermo Fisher (TMO) vs Danaher (DHR): Which Life Sciences Stock Looks Better Positioned? Thermo Fisher (TMO) vs Danaher (DHR): Which Life Sciences Stock Looks Better Positioned? Yahoo Finance
-
Abbott vs Danaher: Which Healthcare Stock Looks Better Positioned Following Earnings? Abbott vs Danaher: Which Healthcare Stock Looks Better Positioned Following Earnings?
-
Danaher Beat Earnings Estimates, so Why Are Investors Still Concerned About Growth? Danaher Beat Earnings Estimates, so Why Are Investors Still Concerned About Growth?
-
Danaher promotes Julie Sawyer Montgomery to CEO Danaher promotes Julie Sawyer Montgomery to CEO
-
-
-
Danaher Appoints Julie Sawyer Montgomery as President and Chief Executive Officer Rainer Blair to retire WASHINGTON, Aug. 3, 2026 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) ("Danaher" or "the Company") announced that the Company's Board of Directors has appointed Julie Sawyer …
More Health Care stocks
- A Agilent Technologies
- CRL Charles River Laboratories
- IQV IQVIA
- MTD Mettler Toledo
- TECH Bio-Techne
- TMO Thermo Fisher Scientific
- WAT Waters Corporation
- ABBV AbbVie